(1.10%) 5 147.50 points
(1.26%) 38 864 points
(1.54%) 17 922 points
(0.15%) $79.07
(1.13%) $2.06
(0.17%) $2 313.60
(0.06%) $26.85
(1.22%) $974.30
(-0.53%) $0.927
(-1.22%) $10.86
(-0.44%) $0.794
(0.49%) $91.57
0.00% $ 64.60
@ $64.59
Wydano: 2 geg. 2024 @ 19:55
Zwrot: 0.02%
Poprzedni sygnał: geg. 2 - 17:48
Poprzedni sygnał:
Zwrot: -0.08 %
Live Chart Being Loaded With Signals
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 2.81M |
Średni wolumen | 2.26M |
Kapitalizacja rynkowa | 4.24B |
EPS | $0 ( 2024-03-18 ) |
Następna data zysków | ( $-0.410 ) 2024-06-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -100.94 |
ATR14 | $0.0900 (0.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-25 | Topper James N | Buy | 1 200 000 | Common Stock |
2024-04-25 | Topper James N | Sell | 19 | Common Stock |
2024-04-25 | Topper James N | Sell | 1 200 000 | Warrant (Right to Buy) |
2024-04-03 | Fuhs Ulrich Martin | Sell | 0 | Common Stock |
2024-04-03 | Fuhs Ulrich Martin | Sell | 75 000 | Stock Option (Right to buy) |
INSIDER POWER |
---|
-20.04 |
Last 100 transactions |
Buy: 5 391 092 | Sell: 8 249 832 |
Wolumen Korelacja
Alpine Immune Sciences Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
NKTR | 0.962 |
BOCN | 0.954 |
IXAQ | 0.954 |
BCSA | 0.952 |
FCNCA | 0.951 |
IZEA | 0.95 |
SZZL | 0.949 |
SVFAU | 0.946 |
MSDA | 0.946 |
NSYS | 0.946 |
10 Najbardziej negatywne korelacje | |
---|---|
AKTX | -0.963 |
ALLR | -0.959 |
APPH | -0.951 |
HCDI | -0.951 |
CASA | -0.949 |
SILK | -0.944 |
JACK | -0.943 |
SHEN | -0.943 |
HAIN | -0.94 |
PERI | -0.939 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Alpine Immune Sciences Korelacja - Waluta/Towar
Alpine Immune Sciences Finanse
Annual | 2023 |
Przychody: | $58.88M |
Zysk brutto: | $58.30M (99.02 %) |
EPS: | $-0.640 |
FY | 2023 |
Przychody: | $58.88M |
Zysk brutto: | $58.30M (99.02 %) |
EPS: | $-0.640 |
FY | 2022 |
Przychody: | $30.06M |
Zysk brutto: | $29.47M (98.01 %) |
EPS: | $-1.730 |
FY | 2021 |
Przychody: | $23.44M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.980 |
Financial Reports:
No articles found.
Alpine Immune Sciences
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej